Russell Investments Group Ltd. Acquires 38,726 Shares of Phreesia, Inc. (NYSE:PHR)

Russell Investments Group Ltd. lifted its stake in Phreesia, Inc. (NYSE:PHR - Free Report) by 36.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 146,118 shares of the company's stock after purchasing an additional 38,726 shares during the quarter. Russell Investments Group Ltd. owned 0.25% of Phreesia worth $3,676,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of PHR. Vanguard Group Inc. raised its holdings in Phreesia by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock worth $121,349,000 after buying an additional 61,048 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Phreesia by 0.8% during the fourth quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock valued at $37,982,000 after acquiring an additional 11,986 shares in the last quarter. State Street Corp raised its holdings in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Geode Capital Management LLC lifted its position in Phreesia by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock valued at $28,397,000 after acquiring an additional 55,934 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock valued at $12,415,000 after purchasing an additional 46,209 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on PHR. Royal Bank of Canada upgraded Phreesia from a "sector perform" rating to an "outperform" rating and boosted their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Canaccord Genuity Group upped their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, March 13th. DA Davidson decreased their price objective on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Needham & Company LLC restated a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, March 13th. Finally, KeyCorp cut their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $31.33.

Phreesia Trading Down 0.1 %

Shares of NYSE PHR traded down $0.03 during midday trading on Tuesday, hitting $23.22. The company's stock had a trading volume of 455,736 shares, compared to its average volume of 434,542. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.36 billion, a P/E ratio of -15.80 and a beta of 0.82. The business's 50 day moving average is $25.84 and its two-hundred day moving average is $24.32.

Insider Buying and Selling at Phreesia

In other news, CFO Balaji Gandhi sold 4,813 shares of the firm's stock in a transaction that occurred on Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $132,261.24. Following the transaction, the chief financial officer now directly owns 144,933 shares of the company's stock, valued at approximately $3,982,758.84. This trade represents a 3.21 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP David Linetsky sold 4,499 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the sale, the senior vice president now owns 217,239 shares of the company's stock, valued at $5,155,081.47. The trade was a 2.03 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 145,804 shares of company stock valued at $4,041,789 in the last quarter. 5.80% of the stock is owned by insiders.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.